Cibs.uahs.arizona.edu
The Center for Innovation in Brain Science University of Arizona
WebFor families and patients wanting more information about Allo Phase 2 Alzheimer’s Clinical Trial: LEARN MORE. Troubled by hot flashes? Learn more about the HF Relief Study being conducted at the University of Arizona to test the effectiveness of a natural product, PhytoSERM, to alleviate hot flashes: hfrelief.org For information about the PhytoSERM …
Actived: Just Now
Building a Resilient Brain To Prevent Alzheimer’s Disease
WebThe bioenergetic changes that occur with the aging brain are at the heart of new research. A new research study led by Fei Yin, PhD, and funded by a $1.1 million grant from the National Institutes of Health, will help determine the role of an Alzheimer’s risk-factor gene in regulating the brain energy production system.
The Center for Innovation in Brain Science University of Arizona
WebOverview The Center for Innovation in Brain Science is an “all brains on deck” research environment designed for highly-integrated, collaborative research through innovative team science. With expertise spanning discovery, translational and clinical science, we are addressing complex issues across four age-associated neurodegenerative diseases. We …
RESEARCH Alzheimer’s, Parkinson’s, Multiple Sclerosis & ALS
WebThe Center for Innovation in Brain Science mission is a collaborative, enabling research environment in which innovation is fostered and developed to address a challenge that have global proportions and individual significance: age-related neurodegenerative diseases. The prevailing paradigm in academic-based therapeutic development is built upon the “bench …
New Study Identifies Connection Between Diabetes Medications, …
WebA new University of Arizona Health Sciences study found that people older than 45 whose Type 2 diabetes was treated with anti-hyperglycemic medications had an increased risk of multiple sclerosis, particularly among women, while anti-hyperglycemic exposure in people younger than 45 reduced that risk. “Our findings reinforce the need …
CIBS Research: Hope on the Horizon for ALS Patients
WebThe Center for Innovation in Brain Science (CIBS) at the University of Arizona is addressing the challenge that, in the 21st century, there is not a single cure for a single neurodegenerative disease and is focused on four age-associated neurodegenerative diseases: Alzheimer’s, Parkinson’s, Multiple Sclerosis and ALS.
Brain’s self-cleaning machinery may be key to Alzheimer’s
WebThe Center for Innovation in Brain Science (CIBS) at the University of Arizona is addressing the challenge that, in the 21st century, there is not a single cure for a single neurodegenerative disease and is focused on four age-associated neurodegenerative diseases: Alzheimer’s, Parkinson’s, Multiple Sclerosis and ALS.
Amyotrophic Lateral Sclerosis (ALS)
WebTraditional drug development, focused on pathological endpoints, has failed to deliver meaningful interventions to halt the progression of neurodegenerative disease. By targeting fundamental cellular processes, such as RNA-protein interactions, we are leading the discovery of a novel class of targets with pre-clinical efficacy across a number of …
News & Events
WebThe Center for Innovation in Brain Science (CIBS) at the University of Arizona is addressing the challenge that, in the 21st century, there is not a single cure for a single neurodegenerative disease and is focused on four age-associated neurodegenerative diseases: Alzheimer’s, Parkinson’s, Multiple Sclerosis and ALS.
Menopause and Cognition: Testing an Alternative to Estrogen …
WebThe Center for Innovation in Brain Science (CIBS) at the University of Arizona is addressing the challenge that, in the 21st century, there is not a single cure for a single neurodegenerative disease and is focused on four age-associated neurodegenerative diseases: Alzheimer’s, Parkinson’s, Multiple Sclerosis and ALS.
Precision Medicine Therapies for Alzheimer's Disease
WebThe paper, “Predictive metabolic networks reveal sex and APOE genotype-specific metabolic signatures and drivers for precision medicine in Alzheimer’s Disease,” was published today in Alzheimer’s and Dementia: The Journal of the Alzheimer’s Association. The APOE gene is involved in making a protein that helps carry cholesterol …
Strategic Partnership Opportunities Neurodegenerative Disease …
WebReal science that really matters. The Center for Innovation in Brain Science combines the institutional excellence of one of the nation’s top-tier research institutions with a highly entrepreneurial biotech ethos. We are building strategic partnerships that can change the standard of health care through advanced therapeutic development to ensure that …
$15.1 Million Grant from NIH advances research into …
WebNIH Grant Advances Center’s Research on Women’s Brains, Menopause and Increased Risk for Alzheimer’s. The Center for Innovation in Brain Science received a $15.1 million grant from the National Institutes on Aging to investigate perimenopausal brain aging. Worldwide, women are twice as likely over their lifetime to develop Alzheimer’s disease.
One Small Molecule, Potential Giant Step to Improve Cognitive …
WebA new $6.1 million study led by Dr. Kathleen Rodgers at the Center for Innovation in Brain Science at the UArizona Health Sciences will test novel small molecules to improve the lives of Alzheimer’s patients.With only five available drugs approved by the U.S. Food and Drug Administration to treat Alzheimer’s disease – and no drugs to …
Clincial Trials Alzheimer’s, Parkinson’s, Multiple Sclerosis & ALS
WebThe Center for Innovation in Brain Science (CIBS) at the University of Arizona is addressing the challenge that, in the 21st century, there is not a single cure for a single neurodegenerative disease and is focused on four age-associated neurodegenerative diseases: Alzheimer’s, Parkinson’s, Multiple Sclerosis and ALS.
Strength in new study with potential to improve the lives of ALS
WebAmyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease that affects nerve cells in the brain and spinal cord, affecting vital functions such as speech, swallowing and breathing. Commonly known as Lou Gehrig’s disease, the disorder is characterized by muscle weakness, stiffness and, eventually, paralysis.As part of the …
How menopause reshapes the brain
WebThat’s just one of many impacts that reduced oestrogen levels can have on the brain, says Brinton. She and her collaborators have found that declining sex-hormone levels have enormous effects on the metabolism and immune status of the brain in both rodents 9 and humans 10.Key to this is oestrogen’s role in regulating the uptake of …
Top Categories
Popular Searched
› Syracuse health center dental
› Healthcare kiosks for hospitals
› Preferred family health services joplin mo
› Christus santa rosa health care
› Gloucester county nj health dept
› Baptist health women's conway
› Health insurance premium trends chart
Recently Searched
› Zambia universal health care coverage
› Ncdhhs health care personnel registry
› Health partners open access formulary
› Mobile health solutions oklahoma
› Mercy health my chart rockford
› National standards for mental health services 2013
› Independent health insurance member contact
› Dorset healthcare pharmacy information
› Pet health insurance companies